Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report) shares rose 5.7% on Thursday . The company traded as high as $4.76 and last traded at $4.76. Approximately 532 shares were traded during trading, a decline of 15% from the average daily volume of 626 shares. The stock had previously closed at $4.50.
Sumitomo Pharma Stock Performance
The stock has a 50 day moving average price of $4.69 and a two-hundred day moving average price of $4.32.
Sumitomo Pharma Company Profile
Sumitomo Pharma Co, Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia.
Recommended Stories
- Five stocks we like better than Sumitomo Pharma
- Bank Stocks – Best Bank Stocks to Invest In
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top 3 Beverage Stocks Pouring Out Profits
- How to Invest in Small Cap Stocks
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
